Your browser doesn't support javascript.
loading
Sequencing and imputation in GWAS: Cost-effective strategies to increase power and genomic coverage across diverse populations.
Quick, Corbin; Anugu, Pramod; Musani, Solomon; Weiss, Scott T; Burchard, Esteban G; White, Marquitta J; Keys, Kevin L; Cucca, Francesco; Sidore, Carlo; Boehnke, Michael; Fuchsberger, Christian.
Afiliação
  • Quick C; Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, Michigan.
  • Anugu P; University of Mississippi Medical Center, Jackson, Mississippi.
  • Musani S; University of Mississippi Medical Center, Jackson, Mississippi.
  • Weiss ST; Harvard Medical School, Boston, Massachusetts.
  • Burchard EG; Channing Department of Network Medicine, Brigham and Women's Hospital, Boston, California.
  • White MJ; Partners HealthCare Personalized Medicine, Boston, Massachusetts.
  • Keys KL; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Cucca F; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California.
  • Sidore C; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Boehnke M; Department of Medicine, University of California San Francisco, San Francisco, California.
  • Fuchsberger C; Istituto di Ricerca Genetica e Biomedica (IRGB), CNR, Monserrato, Italy.
Genet Epidemiol ; 44(6): 537-549, 2020 09.
Article em En | MEDLINE | ID: mdl-32519380
A key aim for current genome-wide association studies (GWAS) is to interrogate the full spectrum of genetic variation underlying human traits, including rare variants, across populations. Deep whole-genome sequencing is the gold standard to fully capture genetic variation, but remains prohibitively expensive for large sample sizes. Array genotyping interrogates a sparser set of variants, which can be used as a scaffold for genotype imputation to capture a wider set of variants. However, imputation quality depends crucially on reference panel size and genetic distance from the target population. Here, we consider sequencing a subset of GWAS participants and imputing the rest using a reference panel that includes both sequenced GWAS participants and an external reference panel. We investigate how imputation quality and GWAS power are affected by the number of participants sequenced for admixed populations (African and Latino Americans) and European population isolates (Sardinians and Finns), and identify powerful, cost-effective GWAS designs given current sequencing and array costs. For populations that are well-represented in existing reference panels, we find that array genotyping alone is cost-effective and well-powered to detect common- and rare-variant associations. For poorly represented populations, sequencing a subset of participants is often most cost-effective, and can substantially increase imputation quality and GWAS power.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genoma Humano / Estudo de Associação Genômica Ampla / Sequenciamento Completo do Genoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Genoma Humano / Estudo de Associação Genômica Ampla / Sequenciamento Completo do Genoma Idioma: En Ano de publicação: 2020 Tipo de documento: Article